IDO1 and ovarian carcinoma: Interestingly, an overlapping effect was observed in the human ovarian cancer cell line SKOV-3, where EPA (20), LIN, and NAV also prolonged the half-life of the IDO1 protein while simultaneously inhibiting its catalytic activity (Supplementary Figures 2A, B).